Citigroup
NMRA icon

Citigroup’s Neumora Therapeutics NMRA Stock Holding History

Citigroup’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.1K Buy
48,793
+4,961
+11% +$12.9K ﹤0.01% 4304
2025
Q4 		$78.5K Buy
43,832
+37,870
+635% +$82.9K ﹤0.01% 4421
2025
Q3 		$10.9K Sell
5,962
-13,164
-69% -$21.3K ﹤0.01% 4998
2025
Q2 		$14K Sell
19,126
-46,721
-71% -$35.4K ﹤0.01% 5138
2025
Q1 		$65.8K Sell
65,847
-41,610
-39% -$71.2K ﹤0.01% 4800
2024
Q4 		$1.14M Buy
107,457
+39,679
+59% +$476K ﹤0.01% 3262
2024
Q3 		$895K Buy
67,778
+47,070
+227% +$549K ﹤0.01% 3346
2024
Q2 		$204K Sell
20,708
-47,750
-70% -$494K ﹤0.01% 3861
2024
Q1 		$941K Buy
68,458
+62,712
+1,091% +$1.01M ﹤0.01% 3079
2023
Q4 		$98K Sell
5,746
-8,670
-60% -$106K ﹤0.01% 4210
2023
Q3 		$203K Buy
+14,416
New +$180K ﹤0.01% 3652

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return